Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

258 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

NCT03722511

Conditions: Carcinoid Syndrome, Carcinoid Tumor of GI System, Chemically-Induced Disorders, +12 more
Locations: University of Kentucky Markey Cancer Center Lexington, Kentucky, United States

View Trial Details

Completed

Gastroenteral-Pancreatic Neuroendocrine Tumors in Taiwan

NCT02102893

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Changhua Christian Hospital Changhua, Taiwan

Chang-Gung Memorial Hospital Taipei, Taiwan

National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2

NCT03271281

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105

NCT03278275

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

HRQoL During PRRT in Patients With NETs

NCT05427032

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
Locations: Not specified

View Trial Details

Completed

Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors

NCT02586844

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

NCT04552847

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Universitaire Ziekenhuizen Leuven Leuven, Belgium

View Trial Details

Completed

Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors

NCT02609737

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Study of Everolimus (RAD001) in Combination With Lenalidomide

NCT01218555

Conditions: Adenoidcystic Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations: Grady Health System Atlanta, Georgia, United States

Emory University Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Completed

18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety

NCT03042416

Conditions: Basal Ganglia Diseases, Brain Diseases, Brain Glioma, +28 more
Locations: University of Alberta Hospital Edmonton, Alberta, Canada

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions